mucormycosis avigan dies clinical decline eli data fake talks lilly ups court ivermectin priced pills remdesivir tablets approved notice sciences sales zenara drugs struggle itolizumab used given mild total arrive

Articles for Favipiravir

From SOS Calls to No Buyers, Drugmakers Struggle With Excess Stock of Covid Drugs as Cases Wane
2 years, 1 month ago

From SOS Calls to No Buyers, Drugmakers Struggle With Excess Stock of Covid Drugs as Cases Wane

News 18  

With Covid-19 almost waning, Indian pharma companies are struggling with the excess stock of key drugs that were in demand during the pandemic, News18.com has learnt. The lobby of more than 7.5 lakh chemists across India says the stock of over Rs 5 crore has been returned to pharma companies after noticing a major dip in sales of these drugs. …

India Drugs Industry Cases Materials Stock Raw Materials
Covid Pill Molnupiravir’s Treatment for 5 Days May Cost Rs 1,600-Rs 3,000
2 years, 11 months ago

Covid Pill Molnupiravir’s Treatment for 5 Days May Cost Rs 1,600-Rs 3,000

News 18  

The anti-viral Covid pill, Molnupiravir, may be priced Rs 40 to Rs 75 per tablet thus making the cost of the entire treatment around Rs 3,000 for five days, the head of Optimus Pharma, one of the 13 companies launching the drug in India, told News18. The recommended dose of Molnupiravir is 800 milligram twice a day for five days, …

India Pharma Covid Drug Molnupiravir Favipiravir Optimus Pharma
​25 Cr Pills, 50 Lakh Vials, Sales of Rs 2,800 Cr: Growth Story of India’s 2 anti-Covid Drugs
3 years, 2 months ago

​25 Cr Pills, 50 Lakh Vials, Sales of Rs 2,800 Cr: Growth Story of India’s 2 anti-Covid Drugs

News 18  

A total of 25 crore pills, 50 lakh vials and sales of Rs 2,800 crore — this is how Indians have purchased two key Covid-19 drugs remdesivir and favipiravir in the last 15 months. What data shows According to data from US-based pharma research company IQVIA, accessed by News18.com, India sold 52 lakh vials of remdesivir injection and around 1.5 …

India Crore Covid Lakh Remdesivir Favipiravir Lakh Vials
In new guidelines, Govt drops use of Ivermectin, HCQ, Favipiravir for COVID treatment
3 years, 6 months ago

In new guidelines, Govt drops use of Ivermectin, HCQ, Favipiravir for COVID treatment

India TV News  

The Union Health Ministry, in its latest set of guidelines, has dropped the use of Ivermectin, HCQ, Favipiravir from COVID-19 treatment. However, guidelines have suggested a 6-minute walk test to Covid infected patients. A 6-minute walk test is an established simple clinical test to assess cardio-pulmonary exercise tolerance. Patients with positive 6-minute walk test may progress to become hypoxic and …

Test Guidelines Covid Walk Govt New Guidelines Favipiravir
Covid-19: Over 5 lakh Favipiravir tablets from UAE arrive in India
3 years, 7 months ago

Covid-19: Over 5 lakh Favipiravir tablets from UAE arrive in India

Hindustan Times  

Amid the unprecedented rise in Covid-19 cases in India, over five lakh Favipiravir Tablets from the UAE reached here on Tuesday. Over five lakh Favipiravir Tablets from the UAE reached India. Thank our close partner & friend UAE for gifting over 5 lakh Favipiravir Tablets," tweeted Arindam Bagchi, Spokesperson of the Ministry of External Affairs. By far the Indian government …

India Uae Favipiravir Tablets
Plea In SC Seeks Authorisation For Use Of Remdesivir, Favipiravir and Tocilizumab For Govt. Purposes And/Or Grant Compulsory Licenses For Their Patents
3 years, 7 months ago

Plea In SC Seeks Authorisation For Use Of Remdesivir, Favipiravir and Tocilizumab For Govt. Purposes And/Or Grant Compulsory Licenses For Their Patents

Live Law  

An Application has been filed in the suo moto matter before the Supreme Court pertaining to the COVID-19 crisis in the country seeking directions to issue authorization for using the patents for government purpose and/or notifying grant of Compulsory Licenses under Patents Act for patent covering drugs Remdesivir, Favipiravir and Tocilizumab. Filed by Jan Swasthya Abhiyan of the Drug Price …

India Drugs Application Patent Centre Drug Act
PIL in SC for CBI Probe for Using Two Antiviral Medicines as Treatment to Covid-19 Patients
4 years, 3 months ago

PIL in SC for CBI Probe for Using Two Antiviral Medicines as Treatment to Covid-19 Patients

News 18  

A plea filed in the Supreme Court has sought registration of an FIR by CBI against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir allegedly as medicines that treat COVID-19 patients without valid licences. Lawyer M L Sharma has filed a PIL in the apex court, alleging the medicines are being manufactured and sold for treating COVID-19 …

India Indian Cbi Pil Treat Medicines Remdesivir
BDR Pharma To Launch Favipiravir Tablets for Treating Covid-19 Patients at Rs 990
4 years, 3 months ago

BDR Pharma To Launch Favipiravir Tablets for Treating Covid-19 Patients at Rs 990

News 18  

New Delhi: Drug firmBDR Pharmaceuticals on Friday said it plans to launch400 mg Favipiravir tablets, used for treating COVID-19 patients, in the country. The ‘BDFAVI’ 400 mg tablets will be priced at Rs 990 for a strip of 10 tablets, BDR Pharma said in a statement. “We aim to make BDFAVI available in sufficient quantities to meet the high demand …

Rs 99 Favipiravir Favipiravir Tablets Bdr Pharma Tablets Bdr
Brinton Pharma Gets DCGI Nod to Launch Favipiravir 400 mg Tablets for Covid-19 Treatment
4 years, 4 months ago

Brinton Pharma Gets DCGI Nod to Launch Favipiravir 400 mg Tablets for Covid-19 Treatment

News 18  

Brinton Pharmaceuticals on Thursday said it has received approval from the Drugs Controller General of India to launch Favipiravir 400 mg tablets under the brand name Faviton for Rs 79 per tablet. The tablets are indicated for the treatment of patients with mild to moderate COVID-19 symptoms, Brinton Pharmaceuticals said in a statement. The tablets will be available across all …

Tablet Tablets Favipiravir Brinton Pharmaceuticals Pharma Gets Faviton Brinton Pharma
Dr. Reddy’s launches Favipiravir in India for COVID-19 treatment
4 years, 4 months ago

Dr. Reddy’s launches Favipiravir in India for COVID-19 treatment

The Hindu  

Dr. Reddy’s Laboratories Ltd. On Wednesday announced the launch of Avigan 200 mg tablets in India. The launch is part of the global licensing agreement with Fujifilm Toyama Chemical Co. Ltd. that grants the Indian drug maker the exclusive rights to manufacture, sell and distribute the tablets in India, Chief Executive Officer of Branded Markets, Dr. Reddy’s Laboratories, M.V. We …

India Covid Reddy Ramana Dr Reddy Favipiravir
Zenara Pharma Receives DCGI Approval to Manufacture, Sell Favipiravir Tablets
4 years, 4 months ago

Zenara Pharma Receives DCGI Approval to Manufacture, Sell Favipiravir Tablets

News 18  

Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, announced that it has received approval from the Drugs Controller General of India, to manufacture and sell Favipiravir tablets as a treatment option for patients with mild to moderate symptoms of COVID-19. Jagadeesh Babu Rangisetty, Co-founder and Managing Director of the firm, said, "In the ongoing pandemic, it has become …

India Zenara Pharma Zenara Zenar Manufacture Sell
Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection
4 years, 4 months ago

Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection

Firstpost  

The Covihalt tablet will be available in 200 mg tablets in a strip of 10 and will cost Rs 49 per tablet in India. Drug major Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name ‘Covihalt’ for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India. Its Covihalt …

India Tablet Lupin Favipiravir Covihalt
Sun Pharma Launches Antiviral Covid-19 Drug Favipiravir in India at Rs 35 Per Tablet
4 years, 4 months ago

Sun Pharma Launches Antiviral Covid-19 Drug Favipiravir in India at Rs 35 Per Tablet

News 18  

India’s Sun Pharmaceutical Industries Ltd said on Tuesday it would soon begin selling its version of favipiravir, becoming the latest generic drugmaker to supply the antiviral to treat COVID-19 in the world’s third worst-hit nation. Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in India, which saw a surge …

India Sun Drug Sun Pharma Favipiravir
Coronavirus India lockdown Day 120 updates | July 22, 2020
4 years, 5 months ago

Coronavirus India lockdown Day 120 updates | July 22, 2020

The Hindu  

The government on Tuesday said it has extended connectivity norms for work from home for IT and BPO companies till December 31. - PTI 7:30 p.m. | Tamil Nadu Tamil Nadu reports single day high of over 5,000 COVID-19 cases, 74 deaths Tamil Nadu on Wednesday reported an all time single day high of 5,849 fresh coronavirus cases, taking the …

Health Singapore Karnataka Tamil Nadu Odisha Kerala Delhi
DCGI sends notice to Glenmark for false claims, overpricing of COVID-19 drug FabiFlu
4 years, 5 months ago

DCGI sends notice to Glenmark for false claims, overpricing of COVID-19 drug FabiFlu

India TV News  

The Drug Controller General of India has sent a show cause notice to Glenmark Pharmaceuticals over 'overpricing' and alleged 'false claims' of its drug Fabiflu. The DCGI also said that Glenmark made claims that Fabiflu alone would suffice as treatment in mild and moderate coronavirus cases and that it is effective for patients with comorbidities. "It has been mentioned in …

False Claims Notice Drug Dcgi Glenmark Fabiflu
Safeguarding your physical and financial well-being with COVID-19 health insurance
4 years, 5 months ago

Safeguarding your physical and financial well-being with COVID-19 health insurance

Hindustan Times  

Covid-19 is a reality that isn’t going away any time soon, and as all of us try and find a few certainties in an uncertain scenario, we can’t help but wonder what next. Insurance policies to the rescue Unsurprisingly, the pandemic has fuelled awareness about health insurance policies with people sharing their nightmarish experiences of the difficulties in getting timely …

Health India Insurance Medical Patients Policies Inr